A lot of older men think that the difficulty of urination is old, not useful, not to go to the doctor and endure the “torment” of urination alone, in fact, this concept is wrong. This is mostly the result of prostate enlargement. The actual fact is that you can find a lot of people who are not able to get a good deal on this kind of things. The incidence of benign prostatic hyperplasia (BPH) is one of the most common benign diseases that cause urinary disorders in middle-aged and elderly men, and the incidence increases with age, usually occurring initially after the age of 40, to greater than 50% at the age of 60, and up to 83% at the age of 80. The main manifestations are frequent incomplete urination, frequent urination (whether the interval between urination is often less than two hours), intermittent urination, urgent urination (not being able to wait to urinate), thin urine line, straining and straining to start urination, and increased nocturia (generally needing to get up more than three times to urinate from sleep to early morning). Several studies have confirmed that BPH is a slowly progressive benign prostate disease whose symptoms progressively worsen as patients age, affecting their quality of life with corresponding complications, such as acute urinary retention, recurrent hematuria, recurrent urinary tract infections, and renal impairment, inguinal hernia, etc. The current principles of treatment for prostate enlargement include 3 parts: watchful waiting, medication, and surgical treatment. BPH is a progressive benign hyperplastic process of the prostate, and after a long period of follow-up, only a few patients with BPH may develop complications such as urinary retention, renal insufficiency, and bladder stones. Therefore, watchful waiting can be an appropriate management for most patients with BPH, especially when the patient’s quality of life has not yet been significantly affected by lower urinary tract symptoms. When the patient’s urinary disturbance significantly affects the patient’s quality of life, we need to intervene with pharmacotherapy. The short-term goal of drug therapy is to relieve the patient’s symptoms of urinary disorders such as dyspareunia, and the long-term goal is to delay the clinical progression of the disease, prevent complications, and maintain a high quality of life for the patient while reducing the side effects of drug therapy. Commonly used medications are Harlequin, Natal, Gottlieb, Terazosin, Paulette, Epradol, and Enestrel (actually it pairs mainly alpha-blockers and 5 alpha-reductase inhibitors, the former can stretch the smooth muscle of the urethra to make it wider and facilitate urination, the latter can block androgen synthesis, stop the process of prostate hypertrophy, and reduce the squeeze on the urethra. ) When even medications fail to improve the patient’s urinary disorder, surgical treatment is required. Especially when repeated urinary retention (inability to urinate after at least one extubation or two), recurrent hematuria, ineffective treatment with 5α-reductase inhibitors, recurrent urinary tract infections, bladder stones, secondary upper urinary tract effusion (with or without renal impairment), patients with BPH combined with large bladder diverticula, inguinal hernia, severe hemorrhoids or prolapse, and clinical judgment of difficulty in achieving therapeutic results without relieving lower urinary tract obstruction, surgical treatment should be considered. Surgical treatment for BPH includes general surgery, laser therapy, high energy ultrasound therapy, and other treatment modalities. The general surgical treatments include transurethral resection of the prostate (TURP), transurethral resection of the prostate (TUIP), and open prostate removal, and TURP is still the “gold standard” of BPH treatment. High-energy focused ultrasound and laser therapy have also been widely used in recent years.